Full history for every metric is available with a Kvantra account
Dignitana AB (publ) (DIGN.ST)
Key financial summary
Financials in SEK| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SEK m | 41 | 47 | 57 | 73 | 86 | 90 | 91 |
| Operating profit | SEK m | -18 | -15 | |||||
| Net profit | SEK m | -38 | -55 | -43 | -22 | -17 | -19 | -16 |
| EPS reported | SEK | -0.25 | -0.20 | |||||
| Operating cashflow per share | SEK | 0.00 | 0.00 | |||||
| Capex per share | SEK | 0.06 | 0.06 | |||||
| FCF per share | SEK | -0.05 | -0.05 | |||||
| Free cash flow | SEK m | -4 | -2 | |||||
| Net debt | SEK m | 4 | 4 | |||||
| Book value equity | SEK m | 7 | 4 | |||||
| Book value per share | SEK | 0.09 | 0.05 | |||||
| Number of shares | m | 77.76 | 80.54 | |||||
| DPS (TTM paid) | SEK | 0.00 | 0.00 |
Financial summary
Financials in SEK| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 10.44 | 40.14 | |||||
| P/S LTM | x | 0.83 | 1.90 | |||||
| P/FCF LTM | x | -18.21 | -80.06 | |||||
| EV/EBITDA LTM | x | -24.73 | -93.79 | |||||
| EV/Sales LTM | x | 0.87 | 1.95 | |||||
| Earnings Yield LTM | % | -25.83% | -11.52% | |||||
| FCF Yield | % | -5.49% | -1.25% | |||||
| Quality | ||||||||
| ROE | % | -269.60% | -266.78% | |||||
| ROIC | % | -103.43% | -103.43% | |||||
| Operating margin | % | -20.37% | -20.37% | |||||
| Gross margin | % | 67.10% | 67.10% | |||||
| FCF/Sales | % | -4.54% | -4.54% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +4.38% | +5.76% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.56 | -0.31 | |||||
| Net Debt/EBITDA | x | -1.36 | -1.36 | |||||
| EBIT/Net interest | x | -7.12 | -7.12 | |||||
| Net debt/market cap | % | 5.82% | 2.35% | |||||
| Net debt/Equity | x | 0.61 | 0.94 | |||||
| Gross debt/equity | x | 1.02 | 1.60 | |||||
Company overview
Dignitana AB (publ) is a medical technology firm that designs, manufactures, and sells specialized medical cooling equipment to markets across the United States and globally. Its primary product, DigniCap, is a unique scalp cooling system engineered to help prevent hair loss in patients receiving particular chemotherapy treatments, specifically those battling breast cancer. The company, which established its operations in 2007, is based in Lund, Sweden.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Dignitana AB (publ) (DIGN.ST)
Dignitana AB (publ) is a medical technology firm that designs, manufactures, and sells specialized medical cooling equipment to markets across the United States and globally. Its primary product, DigniCap, is a unique scalp cooling system engineered to help prevent hair loss in patients receiving particular chemotherapy treatments, specifically those battling breast cancer. The company, which established its operations in 2007, is based in Lund, Sweden.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free